[gnso-gac-closed-generics] Closed Generics Asynchronous Work

Tue May 23 23:49:53 UTC 2023

Hi Kathy,

Per your request, I’ve gone through the Remaining Red Lines<https://docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit> table and added which section/block each Red Line came from in the v2 document<https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1>. If you look just beneath the title of each topic (e.g. “Scoring”) you will find the relevant information (“From v2 Discussion Draft<https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1>: Section IV (Evaluation) #6”). I hope this helps.

Kind regards,
Christian

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> on behalf of Kathy Kleiman <Kathy at KathyKleiman.com>
Date: Tuesday, May 23, 2023 at 3:37 PM
To: "gnso-gac-closed-generics at icann.org" <gnso-gac-closed-generics at icann.org>, Melissa Peters Allgood <melissa.allgood at icann.org>
Subject: Re: [gnso-gac-closed-generics] Closed Generics Asynchronous Work

Hi Melissa,

Is there any way that you/Christian could go through #1, Remaining Red Lines Table, in the left column and identify which "Block" of our Framework the section came from, e.g.,

- Application, Evaluation or Post-delegation?

Out of context, things are looking a little duplicative and it may be because they are coming from different sections of our Framework.  If you remember, it was my job, with Greg specifically to move some items from Evaluation to Application (keeping them in Evaluation, but also giving the Applicant an opportunity to provide input directly on an issue to be evaluated by the Panel).

If we can see these section headings a little more clearly, it will provide some usual context for the sections we are discussing.

Best and tx, Kathy
On 5/22/2023 6:48 PM, Melissa Peters Allgood wrote:
Hello again,

Many thanks again for the strong spirit of compromise shared by all during today’s call.

This is the email chain that encapsulates remaining work, specifically:

  1.  Remaining Red lines table [docs.google.com]<https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWCPrAc5k$>
  2.  Add notable concerns to v3 [docs.google.com]<https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWAgn-Cok$>.

Please don’t hesitate to reach out if you have any questions.

Melissa

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org><mailto:gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa Peters Allgood <melissa.allgood at icann.org><mailto:melissa.allgood at icann.org>
Date: Monday, May 22, 2023 at 8:08 AM
To: "gnso-gac-closed-generics at icann.org"<mailto:gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org><mailto:gnso-gac-closed-generics at icann.org>
Subject: Re: [gnso-gac-closed-generics] Closed Generics Asynchronous Work

Hello,

Just a reminder to review and respond to the work detailed below. My thanks to those who have already done so.

See you later today,
Melissa

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org><mailto:gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa Peters Allgood <melissa.allgood at icann.org><mailto:melissa.allgood at icann.org>
Date: Thursday, May 18, 2023 at 2:50 PM
To: "gnso-gac-closed-generics at icann.org"<mailto:gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org><mailto:gnso-gac-closed-generics at icann.org>
Subject: [gnso-gac-closed-generics] Closed Generics Asynchronous Work

Hello all,

While you have come a long way toward a draft framework, significant work remains with very little time to do it. I encourage you to view the work remaining through a lens of compromise.

Remaining Red Lines [docs.google.com]<https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQYSpUk18Q$>
This table reflects where each remaining red line issue currently stands. The group has recently worked on the vast majority of these and many issues within the table offer proposed compromise. At this point, your positions on each issue are well known and there is no need to restate them. Instead, in this table I ask you find compromise with the language proposed OR offer possible solutions that meet your needs, as well as the needs of your colleagues.

Due to time constraints, it is now incumbent upon each of you to find strong support for your priority issues within the red line table in order for the issue to be included within the Closed Generic Framework v3 document. [docs.google.com]<https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$>

Detailed Solutions to your “Notable Concerns” in v3 Document
If you flagged specific text as a “notable concern” during our red line discussions (this was the final question I asked for each bit of text under discussion) then please share proposed solutions to your concern(s) via comments in the v3 document [docs.google.com]<https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$> as soon as possible.

Minority Statements
We haven’t seen strong support for this option.

Remaining Calls

  1.  22 May 2023 at 20:00 UTC
  2.  24 May 2023 at 20:00 UTC

Thank you for your continued hard work, especially asynchronously. The finish line is in sight.

All the best,
Melissa

_______________________________________________

gnso-gac-closed-generics mailing list

gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>

https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics

_______________________________________________

By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230523/feda7f92/attachment-0001.html>